Literature DB >> 11814502

Hysterectomy rates in the United States 1990-1997.

Cynthia M Farquhar1, Claudia A Steiner.   

Abstract

OBJECTIVE: To assess hysterectomy rates, type of hysterectomy, and other factors associated within the United States from 1990-1997.
METHODS: A descriptive statistical analysis of national discharge data was undertaken. Data from the nationwide Inpatient Sample of the Healthcare Cost and Utilization Project (from which national estimates are generated based on a 20% stratified sample of US community hospitals) were used for the years 1990-1997. All women who underwent hysterectomy were identified using International Classification of Diseases, 9th Revision, Clinical Modification, procedure codes. Outcome measures included rate, type of hysterectomy, age of patients, length of stay, total hospital charges, and diagnostic categories.
RESULTS: Rates of hysterectomy have not changed significantly over the years from 1990-1997. Rates for hysterectomy in 1990 were 5.5 per 1000 women and increased slightly by 1997 to 5.6 per 1000 women. The type of hysterectomy has changed, with laparoscopic hysterectomy accounting for 9.9% of cases by 1997, with a concomitant decline in abdominal hysterectomy but no substantial change in vaginal hysterectomy rates. Length of stay decreased and total charges increased for all types of hysterectomy. Vaginal hysterectomy and laparoscopic hysterectomy are associated with shorter length of stay than abdominal hysterectomy. Abdominal hysterectomy is the most common procedure (63.0% in 1997).
CONCLUSION: The majority of hysterectomies are abdominal, and the most common indication is uterine fibroids. The introduction of alternative techniques for controlling abnormal uterine bleeding such as endometrial ablation has not had an impact on hysterectomy rates, and there has only been a limited uptake of laparoscopic approaches.

Entities:  

Mesh:

Year:  2002        PMID: 11814502     DOI: 10.1016/s0029-7844(01)01723-9

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  159 in total

1.  Intake of fruit, vegetables, and carotenoids in relation to risk of uterine leiomyomata.

Authors:  Lauren A Wise; Rose G Radin; Julie R Palmer; Shiriki K Kumanyika; Deborah A Boggs; Lynn Rosenberg
Journal:  Am J Clin Nutr       Date:  2011-11-09       Impact factor: 7.045

2.  Role of microRNA-21 and programmed cell death 4 in the pathogenesis of human uterine leiomyomas.

Authors:  J Browning Fitzgerald; Vargheese Chennathukuzhi; Faezeh Koohestani; Romana A Nowak; Lane K Christenson
Journal:  Fertil Steril       Date:  2012-06-22       Impact factor: 7.329

3.  Association of germline mutations in the fumarate hydratase gene and uterine fibroids in women with hereditary leiomyomatosis and renal cell cancer.

Authors:  Laveta Stewart; Gladys M Glenn; Pamela Stratton; Alisa M Goldstein; Maria J Merino; Margaret A Tucker; W Marston Linehan; Jorge R Toro
Journal:  Arch Dermatol       Date:  2008-12

4.  Racial differences in fibroid prevalence and ultrasound findings in asymptomatic young women (18-30 years old): a pilot study.

Authors:  Erica E Marsh; Geraldine E Ekpo; Eden R Cardozo; Maureen Brocks; Tanaka Dune; Leeber S Cohen
Journal:  Fertil Steril       Date:  2013-03-15       Impact factor: 7.329

5.  Vitamin d and the risk of uterine fibroids.

Authors:  Donna Day Baird; Michael C Hill; Joel M Schectman; Bruce W Hollis
Journal:  Epidemiology       Date:  2013-05       Impact factor: 4.822

6.  A prospective study of dairy intake and risk of uterine leiomyomata.

Authors:  Lauren A Wise; Rose G Radin; Julie R Palmer; Shiriki K Kumanyika; Lynn Rosenberg
Journal:  Am J Epidemiol       Date:  2009-12-02       Impact factor: 4.897

7.  Estrogen receptor alpha (ERalpha) phospho-serine-118 is highly expressed in human uterine leiomyomas compared to matched myometrium.

Authors:  Tonia L Hermon; Alicia B Moore; Linda Yu; Grace E Kissling; Frank J Castora; Darlene Dixon
Journal:  Virchows Arch       Date:  2008-10-14       Impact factor: 4.064

8.  Evaluating risk factors for differences in fibroid size and number using a large electronic health record population.

Authors:  Michael J Bray; Eric S Torstenson; Sarah H Jones; Todd L Edwards; Digna R Velez Edwards
Journal:  Maturitas       Date:  2018-05-11       Impact factor: 4.342

9.  Persistent organic pollutants (POPs) and fibroids: results from the ENDO study.

Authors:  Britton Trabert; Zhen Chen; Kurunthachalam Kannan; C Matthew Peterson; Anna Z Pollack; Liping Sun; Germaine M Buck Louis
Journal:  J Expo Sci Environ Epidemiol       Date:  2014-05-07       Impact factor: 5.563

10.  Trends in the national distribution of laparoscopic hysterectomies from 2003 to 2010.

Authors:  Jinhyung Lee; Kristofer Jennings; Mostafa A Borahay; Ana M Rodriguez; Gokhan S Kilic; Russell R Snyder; Pooja R Patel
Journal:  J Minim Invasive Gynecol       Date:  2014-01-24       Impact factor: 4.137

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.